139 related articles for article (PubMed ID: 33875426)
1. Effect of Clofazimine Concentration on QT Prolongation in Patients Treated for Tuberculosis.
Abdelwahab MT; Court R; Everitt D; Diacon AH; Dawson R; Svensson EM; Maartens G; Denti P
Antimicrob Agents Chemother; 2021 Jun; 65(7):e0268720. PubMed ID: 33875426
[TBL] [Abstract][Full Text] [Related]
2. Effects of Bedaquiline Combined with Fluoroquinolone and/or Clofazimine on QT Interval in Patients with Multidrug-Resistant Tuberculosis: a Retrospective Study.
Li R; Ma JB; Yang H; Yang H; Yang XJ; Wu YQ; Ren F
Microbiol Spectr; 2023 Aug; 11(4):e0104823. PubMed ID: 37310268
[TBL] [Abstract][Full Text] [Related]
3. QT Interval Prolongation with One or More QT-Prolonging Agents Used as Part of a Multidrug Regimen for Rifampicin-Resistant Tuberculosis Treatment: Findings from Two Pediatric Studies.
Ali AM; Radtke KK; Hesseling AC; Winckler J; Schaaf HS; Draper HR; Solans BP; van der Laan L; Hughes J; Fourie B; Nielsen J; Garcia-Prats AJ; Savic RM
Antimicrob Agents Chemother; 2023 Jul; 67(7):e0144822. PubMed ID: 37358463
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and Cardiac Safety of Bedaquiline-Based Therapy for Drug-Resistant Tuberculosis: A Prospective Cohort Study.
Brust JCM; Gandhi NR; Wasserman S; Maartens G; Omar SV; Ismail NA; Campbell A; Joseph L; Hahn A; Allana S; Hernandez-Romieu AC; Zhang C; Mlisana K; Viljoen CA; Zalta B; Ebrahim I; Franczek M; Master I; Ramangoaela L; Te Riele J; Meintjes G
Clin Infect Dis; 2021 Dec; 73(11):2083-2092. PubMed ID: 33882121
[TBL] [Abstract][Full Text] [Related]
5. QT prolongation in the STREAM Stage 1 Trial.
Hughes G; Bern H; Chiang CY; Goodall RL; Nunn AJ; Rusen ID; Meredith SK
Int J Tuberc Lung Dis; 2022 Apr; 26(4):334-340. PubMed ID: 35351238
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and cardiac safety of clofazimine in children with rifampicin-resistant tuberculosis.
Ali AM; P Solans B; Hesseling AC; Winckler J; Schaaf HS; Draper HR; van der Laan L; Hughes J; Fourie B; Nielsen J; Wiesner L; Garcia-Prats AJ; Savic RM
Antimicrob Agents Chemother; 2024 Jan; 68(1):e0079423. PubMed ID: 38112526
[TBL] [Abstract][Full Text] [Related]
7. Moxifloxacin Pharmacokinetics, Cardiac Safety, and Dosing for the Treatment of Rifampicin-Resistant Tuberculosis in Children.
Radtke KK; Hesseling AC; Winckler JL; Draper HR; Solans BP; Thee S; Wiesner L; van der Laan LE; Fourie B; Nielsen J; Schaaf HS; Savic RM; Garcia-Prats AJ
Clin Infect Dis; 2022 Apr; 74(8):1372-1381. PubMed ID: 34286843
[TBL] [Abstract][Full Text] [Related]
8. Effects on the QT Interval of a Gatifloxacin-Containing Regimen versus Standard Treatment of Pulmonary Tuberculosis.
Olliaro PL; Merle C; Mthiyane T; Bah B; Kassa F; Amukoye E; N Diaye A; Perronne C; Lienhardt C; McIlleron H; Fielding K
Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28438924
[TBL] [Abstract][Full Text] [Related]
9. Dostarlimab, an anti-programmed death-1 monoclonal antibody, does not cause QT prolongation in patients with solid tumours: A concentration-QT analysis.
Kuchimanchi M; Dabrowski C; Lu S; Melhem M
Br J Clin Pharmacol; 2023 Jul; 89(7):2272-2282. PubMed ID: 36823349
[TBL] [Abstract][Full Text] [Related]
10. T-wave morphology abnormalities in the STREAM stage 1 trial.
Hughes G; Young WJ; Bern H; Crook A; Lambiase PD; Goodall RL; Nunn AJ; Meredith SK
Expert Opin Drug Saf; 2024 Apr; 23(4):469-476. PubMed ID: 38462751
[TBL] [Abstract][Full Text] [Related]
11. Model-Predicted Impact of ECG Monitoring Strategies During Bedaquiline Treatment.
van Beek SW; Tanneau L; Meintjes G; Wasserman S; Gandhi NR; Campbell A; Viljoen CA; Wiesner L; Aarnoutse RE; Maartens G; Brust JCM; Svensson EM
Open Forum Infect Dis; 2022 Aug; 9(8):ofac372. PubMed ID: 36043179
[TBL] [Abstract][Full Text] [Related]
12. Concentration-QT modelling shows no evidence of clinically significant QT interval prolongation with capivasertib at expected therapeutic concentrations.
Voronova V; Cullberg M; Delff P; Parkinson J; Dota C; Schiavon G; Maroj B; Rekić D; Cheung SYA
Br J Clin Pharmacol; 2022 Feb; 88(2):858-864. PubMed ID: 34309049
[TBL] [Abstract][Full Text] [Related]
13. ECG monitoring in STREAM Stage 1: can we identify those at increased risk of QT prolongation?
Hughes G; Bern H; Chiang CY; Goodall RL; Nunn AJ; Rusen ID; Meredith SK
Int J Tuberc Lung Dis; 2022 Nov; 26(11):1065-1070. PubMed ID: 36281045
[No Abstract] [Full Text] [Related]
14. Lack of effect of perampanel on QT interval duration: Results from a thorough QT analysis and pooled partial seizure Phase III clinical trials.
Yang H; Laurenza A; Williams B; Patten A; Hussein Z; Ferry J
Epilepsy Res; 2015 Aug; 114():122-30. PubMed ID: 26088895
[TBL] [Abstract][Full Text] [Related]
15. Combination of olanzapine and samidorphan has no clinically relevant effects on ECG parameters, including the QTc interval: Results from a phase 1 QT/QTc study.
Sun L; Yagoda S; Xue H; Brown R; Nangia N; McDonnell D; Rege B; von Moltke L; Darpo B
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jun; 100():109881. PubMed ID: 32004636
[TBL] [Abstract][Full Text] [Related]
16. Exposure-QT analysis for sonidegib (LDE225), an oral inhibitor of the hedgehog signaling pathway, for measures of the QT prolongation potential in healthy subjects and in patients with advanced solid tumors.
Quinlan M; Zhou J; Hurh E; Sellami D
Eur J Clin Pharmacol; 2016 Dec; 72(12):1427-1432. PubMed ID: 27663457
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the effect of the EGFR antibody-drug conjugate ABT-414 on QT interval prolongation in patients with advanced solid tumors likely to over-express EGFR.
Munasinghe WP; Mittapalli RK; Li H; Hoffman DM; Holen KD; Menon RM; Xiong H
Cancer Chemother Pharmacol; 2017 May; 79(5):915-922. PubMed ID: 28349167
[TBL] [Abstract][Full Text] [Related]
18. Assessing Prolongation of the Corrected QT Interval with Bedaquiline and Delamanid Coadministration to Predict the Cardiac Safety of Simplified Dosing Regimens.
Tanneau L; Karlsson MO; Rosenkranz SL; Cramer YS; Shenje J; Upton CM; Morganroth J; Diacon AH; Maartens G; Dooley KE; Svensson EM
Clin Pharmacol Ther; 2022 Oct; 112(4):873-881. PubMed ID: 35687528
[TBL] [Abstract][Full Text] [Related]
19. Serial electrocardiogram recordings revealed a high prevalence of QT interval prolongation in patients with tuberculosis receiving fluoroquinolones.
Ju KS; Lee RG; Lin HC; Chen JH; Hsu BF; Wang JY; Van Dong N; Yu MC; Lee CH
J Formos Med Assoc; 2023 Dec; 122(12):1255-1264. PubMed ID: 37268474
[TBL] [Abstract][Full Text] [Related]
20. A Thorough QT Study of the Combination Glecaprevir + Pibrentasvir on Cardiac Repolarization in Healthy Subjects.
Oberoi RK; Zhao W; Rosebraugh M; Mensa F; Wang H; Liu W
Clin Ther; 2020 Jul; 42(7):1317-1329. PubMed ID: 32622784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
